Skip to main content

Navigation group

Type at least 3 characters
517,184 articles

Articles

Brief Research Report

Accepted on 30 Apr 2024

EX VIVO CHARACTERIZATION OF ACUTE MYELOID LEUKEMIA PATIENTS UNDERGOING HYPOMETHYLATING AGENTS AND VENETOCLAX REGIMEN REVEALS A VENETOCLAX-SPECIFIC EFFECT ON NON-SUPPRESSIVE REGULATORY T CELLS AND BONA FIDE PD-1 + TIM3 + EXHAUSTED CD8 + T CELLS

in Cancer Immunity and Immunotherapy

  • Giulia Corradi
  • Dorian Forte
  • Gianluca Cristiano
  • Andrea Polimeno
  • Marilena Ciciarello
  • Valentina Salvestrini
  • Michele CAVO
  • Darina Ocadlikova
  • Antonio Curti
Frontiers in Immunology
doi 10.3389/fimmu.2024.1386517